Please complete the CAPTCHA to continue
@gilead.com
✓
7 phones found area 619, 858, 973, and 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Simon Fletcher is listed as Vice President, Head of Hepatitis, Herpes, Respiratory and Emerging Viruses Research Group at Gilead Sciences at Gilead Sciences, based in San Mateo, California, United States. AeroLeads shows a work email signal at gilead.com, phone signal with area code 619, 858, 973, 650, and a matched LinkedIn profile for Simon Fletcher.
Simon Fletcher previously worked as Vice President at Gilead Sciences and Executive Director at Gilead Sciences. Simon Fletcher holds Ph.D., Virology from University Of Cambridge.
This section adds company-level context without repeating Simon Fletcher's masked contact details.
AeroLeads found 2 current-domain work email signals for Simon Fletcher. Compare company email patterns before reaching out.
Highly motivated, innovative and collaborative scientist with 25 years of experience in virology and immunology, with broad experience in drug discovery and development. This includes:- Extensive experience developing research strategies, as well as leading discovery and supporting development of direct-acting antivirals and immunomodulatory agents. - More than 20 years of management and leadership experience in small biotech (Anadys), medium biopharma (Gilead) and large pharma (Roche); currently lead team of 40+ scientists.- Extensive virology experience, including hepatitis viruses (HBV, HCV, HDV), respiratory viruses (e.g., RSV, SARS-CoV-2) and herpesviruses (e.g., CMV, HSV).- Broad immunology experience, including discovery and development of diverse immune modulators (e.g., TLR agonists, checkpoint inhibitors, therapeutic vaccines).- Experience with discovering and developing novel agents with different modalities (small molecules, antibodies and other biologics, viral vector vaccines).- Experience supporting agents from early discovery through Phase 2 and various regulatory filings (IND, CTA, SCOTT, investigator brochures, product labels).- Extensive experience interacting with functions across biopharmaceutical organizations (e.g., research, clinical development, corporate development, commercial, regulatory, med affairs).- Extensive experience working with diverse external partners (CRO, biotech and pharma organizations, as well as academic groups). - Experience with in-licensing, acquisition and out-licensing deals.Specialties: virology; antivirals; immunology; innate immunity; immunotherapies; viral hepatitis; HBV; HCV; HDV; herpesviruses; CMV; HSV; RSV; COVID; SARS-CoV-2; pandemic preparedness; translational medicine; molecular biology; cell biology
Listed skills include Drug Discovery, Immunology, Virology, Biomarkers, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Foster City, CA, US
- Lead team of ~45 focused on developing novel treatments for HBV, HDV, respiratory viruses, herpesviruses, neglected/emerging viruses, and viruses with pandemic potential.- Responsible for the strategy, portfolio, and budget for all non-HIV virology research- Played important role in various in-licensing/acquisition deals (e.g., MYR Pharmaceuticals.
Switzerland 🇨🇭, CH
- Project leader of three inter-disciplinary drug discovery programs for HBV and HCV.- Led two strategy teams focused on immunomodulation and HBV, respectively, and was a key contributor to a year-long exercise identifying new research areas.- Discovery leader of an HBV experimental medicine team. Led and coordinated a translational research program.
US
- Translational medicine leader for the ANA773 and ANA975 HCV programs. ANA773 and ANA975 activate host immunity via TLR7. - Project leader of a cross-functional discovery program, which included HTS against multiple targets and extensive lead optimization. Program produced a clinical candidate, ANA773.- Managed multiple IND-enabling preclinical activities.
Switzerland 🇨🇭, CH
- Investigation of interferon-alpha mediated inhibition of HCV replication.- Development of a novel selectable HCV monocistronic replicon.
US
- Set up and optimization of the Ribosome Display methodology as a drug discovery tool.
Other employees you can reach at gilead.com. View company contacts →
Robert A. Ladd
Colleague at Gilead Sciences
New York City Metropolitan Area, United States, United States
View →
LR
Lily Rasovsky
Colleague at Gilead Sciences
Pleasanton, California, United States, United States
View →
ML
María López Cavanillas
Colleague at Gilead Sciences
Greater Madrid Metropolitan Area, Spain
View →
HD
Harriet Dickinson
Colleague at Gilead Sciences
London, England, United Kingdom, United Kingdom
View →
X(
Xiaohui (Gianna) Huang
Colleague at Gilead Sciences
United States, United States
View →
JS
Jennifer Souza
Colleague at Gilead Sciences
Menlo Park, California, United States, United States
View →
LM
Lidia Macedo
Colleague at Gilead Sciences
Venustiano Carranza, Mexico City, Mexico, Mexico
View →
KF
Kerri Fitzpatrick Ms, Rn, Ocn
Colleague at Gilead Sciences
Greater Chicago Area, United States, United States
View →
AN
Anthony Nieto
Colleague at Gilead Sciences
Oceanside, California, United States, United States
View →
KT
Ken Torreggiani
Colleague at Gilead Sciences
Albany, New York, United States, United States
View →
Quick answers generated from the profile data available on this page.
Simon Fletcher works for Gilead Sciences.
Simon Fletcher is listed as Vice President, Head of Hepatitis, Herpes, Respiratory and Emerging Viruses Research Group at Gilead Sciences at Gilead Sciences.
AeroLeads has found 2 work email signals at @gilead.com for Simon Fletcher at Gilead Sciences.
AeroLeads has found 7 phone signal(s) with area code 619, 858, 973, 650 for Simon Fletcher at Gilead Sciences.
Simon Fletcher is based in San Mateo, California, United States while working with Gilead Sciences.
Simon Fletcher has worked for Gilead Sciences, Roche, Anadys Pharmaceuticals, and Cambridge Antibody Technology.
Simon Fletcher's colleagues at Gilead Sciences include Robert A. Ladd, Lily Rasovsky, María López Cavanillas, Harriet Dickinson, and Xiaohui (Gianna) Huang.
You can use AeroLeads to view verified contact signals for Simon Fletcher at Gilead Sciences, including work email, phone, and LinkedIn data when available.
Simon Fletcher holds Ph.D., Virology from University Of Cambridge.
Simon Fletcher is listed with skills including Drug Discovery, Immunology, Virology, Biomarkers, Drug Development, Assay Development, Molecular Biology, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts